BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 7938718)

  • 1. [Permanent venous access through a +portacath reservoir in patients receiving prolonged chemotherapy].
    García H; Díaz R; Pablo Barés J; Nevah E; Fábrega JM
    Rev Med Panama; 1994 Jan; 19(1):8-12. PubMed ID: 7938718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term experience with a totally implanted catheter system in gynecologic oncologic patients.
    Koonings PP; Given FT
    J Am Coll Surg; 1994 Feb; 178(2):164-6. PubMed ID: 8173727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A peripherally implanted permanent central venous access device.
    Morris P; Buller R; Kendall S; Anderson B
    Obstet Gynecol; 1991 Dec; 78(6):1138-42. PubMed ID: 1945224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgically implanted subcutaneous venous access devices in cancer patients.
    Repelaer van Driel OJ; Kuin CM; van de Velde CJ
    Neth J Surg; 1988 Jun; 40(4):97-9. PubMed ID: 3217033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral infusion ports for central venous access in patients with gynecologic malignancies.
    Cunningham MJ; Collins MB; Kredentser DC; Malfetano JH
    Gynecol Oncol; 1996 Mar; 60(3):397-9. PubMed ID: 8774645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of central venous catheters for prolonged venous access in cancer chemotherapy.
    Rajoor BG; Charak BS; Banavali SD; Iyer RS; Saikia TK; Gopal R; Advani SH
    J Assoc Physicians India; 1990 May; 38(5):340-2. PubMed ID: 2387816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of mechanical malfunction in low-profile subcutaneous implantable venous access devices in patients receiving chemotherapy for gynecologic malignancies.
    Subramaniam A; Kim KH; Bryant SA; Kimball KJ; Huh WK; Straughn JM; Estes JM; Alvarez RD
    Gynecol Oncol; 2011 Oct; 123(1):54-7. PubMed ID: 21742372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged venous access in cancer patients.
    Guenier C; Ferreira J; Pector JC
    Eur J Surg Oncol; 1989 Dec; 15(6):553-5. PubMed ID: 2599125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low infection rate and long durability of nontunneled silastic catheters. A safe and cost-effective alternative for long-term venous access.
    Raad I; Davis S; Becker M; Hohn D; Houston D; Umphrey J; Bodey GP
    Arch Intern Med; 1993 Aug; 153(15):1791-6. PubMed ID: 8392831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High rate of complications associated with peripherally inserted central venous catheters in patients with solid tumours.
    Cheong K; Perry D; Karapetis C; Koczwara B
    Intern Med J; 2004 May; 34(5):234-8. PubMed ID: 15151668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Externalized Groshong catheters and Hickman ports for central venous access in gynecologic oncology patients.
    Gleeson NC; Fiorica JV; Mark JE; Pinelli DM; Hoffman MS; Roberts WS; Cavanagh D
    Gynecol Oncol; 1993 Dec; 51(3):372-6. PubMed ID: 8112648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Venous access devices in oncology].
    Maňásek V; Soumarová R; Kociánová I; Maňásková M
    Klin Onkol; 2012; 25(1):9-16. PubMed ID: 22348215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Totally implantable central venous access ports. Analysis of 700 cases.
    Barbetakis N; Asteriou C; Kleontas A; Tsilikas C
    J Surg Oncol; 2011 Nov; 104(6):654-6. PubMed ID: 21671465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable port devices are catheters of choice for administration of chemotherapy in pediatric oncology patients-a clinical experience in Pakistan.
    Hooda B; Lalani G; Fadoo Z; Billoo G
    Ann N Y Acad Sci; 2008 Sep; 1138():43-6. PubMed ID: 18837881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Implanted venous access system in oncology. Review of 296 cases].
    Guenier C; Nogaret JM; Ferreira J; Lorent I; Pector JC
    Ann Chir; 1990; 44(5):388-91. PubMed ID: 2372203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with an implantable venous access system for chemotherapy.
    Pettengell R; Davies AJ; Harvey VJ
    N Z Med J; 1991 Jul; 104(915):284-5. PubMed ID: 1852329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Totally implanted device for long-term intravenous chemotherapy: experience in 123 adult patients with solid neoplasms.
    Puig-la Calle J; López Sánchez S; Piedrafita Serra E; Allende Honorato L; Artigas Raventós V; Puig la Calle J
    J Surg Oncol; 1996 Aug; 62(4):273-8. PubMed ID: 8691841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central venous catheters for chemotherapy of solid tumors--our results in the last 5 years.
    Zganjer M; Cizmić A; Butković D; Matolić M; Karaman-Ilić M; Stepan J
    Coll Antropol; 2008 Sep; 32(3):767-70. PubMed ID: 18982750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central venous catheters for infusion therapy in gastrointestinal cancer. A comparative study of tunnelled centrally placed catheters and peripherally inserted central catheters.
    Snelling R; Jones G; Figueredo A; Major P
    J Intraven Nurs; 2001; 24(1):38-47. PubMed ID: 11836843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Implantable catheter systems].
    Willnow U
    Praxis (Bern 1994); 1998 Sep; 87(36):1135-9. PubMed ID: 9782741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.